Skip to Content

We use cookies to give you the best possible experience on our website.

Small arrow Latest News

See the latest news from the innovation community.

Innovation Technology Payment (ITP) launch

The Innovation and Technology Payment (ITP) launched on the 15th June.   The Innovation and Technology Payment (ITP) builds on the Innovation and Technology Tariff (ITT) and...

2017 NHS Innovation Accelerator (NIA) now open

Applications for the 2017 NHS Innovation Accelerator (NIA) are now open until 26th July 2017. This year the NIA is seeking local, national and international innovations that address the following...
Small arrow Featured Case Studies

Review a selection of Case Studies submitted to the portal.



Case study arrowAtrial Fibrillation is the most common heart rhythm disturbance in the UK and Ireland: it affects around 2 million people each year and is responsible for one third of all strokes. AF and AF-related illness costs the NHS over £2.2 billion each year - and rising.

Reduction of strokes caused by Atrial Fibrillation (AF) is a key shared priority for all AHSNs, with the Innovation Agency, Oxford, Imperial College Health Partners, UCL Partners and North East & North Cumbria AHSNs championing this area.

AliveCor is a simple and highly effective handheld ECG.

This programme is an example of cross-AHSN collaboration: scaling is supported by five AHSNs and AliveCor EU General Manager, Francis White, a NHS National Innovation Accelerator fellow.

The device supports effective AF diagnosis in primary care; speeds up diagnosis & reduces outpatient appointments

It is inexpensive for patients to buy (£100), supporting self-management.

Impact so far

Support from the AHSNs has helped increase the number of GPs and patients using the device by over 300% - from 1,600 to 5,100 active users

The device was used to record over 1million ECGs

• Around 72,000 AF recordings were captured via ECGs



What's next?

Community pharmacists will be delivering a pan-London AF screening programme, supported by the AHSNs, during 2016

The AHSNs will use their networks to support NHS Innovation Accelerator Fellow Francis White to raise awareness of this innovation

An evaluation is being undertaken to establish the economic potential of the innovation, by avoiding unnecessary admissions or cost avoidance to secondary care / A&E

Funding source Logo


Contact Name Martin Leaver, Oxford AHSN Email address

No comments yet. Be the first.
// ]]>